Blastic Plasmacytoid Dendritic Cell Neoplasm
📧 Sign up to get email alerts when something new happens for Blastic Plasmacytoid Dendritic Cell Neoplasm.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-07-26FDA Approved: ELZONRIS — Supplemental Application (Stemline Therapeutics, Inc.)
FDA approves a supplemental application for ELZONRIS (tagraxofusp) from Stemline Therapeutics, Inc. The action updates the drug's labeling/i…
-
FDA approval · 2022-11-03FDA Approved: ELZONRIS — Supplemental Application (Stemline Therapeutics, Inc.)
FDA has approved a supplemental application for ELZONRIS (tagraxofusp) submitted by Stemline Therapeutics, Inc., reflecting an update to its…
-
FDA approval · 2022-10-27FDA Approved: ELZONRIS — Supplemental Application (Stemline Therapeutics, Inc.)
The FDA approved a supplemental application for ELZONRIS (tagraxofusp) from Stemline Therapeutics, Inc.
-
FDA approval · 2018-12-21FDA Approved: ELZONRIS — Original Application (Stemline Therapeutics, Inc.)
FDA approves ELZONRIS (tagraxofusp) from Stemline Therapeutics in the original application for blastic plasmacytoid dendritic cell neoplasm …